[PDF] Top 20 Rational Computational Study for New Kinase Inhibitors
Has 10000 "Rational Computational Study for New Kinase Inhibitors" found on our website. Below are the top 20 most common "Rational Computational Study for New Kinase Inhibitors".
Rational Computational Study for New Kinase Inhibitors
... The Lipinski's Rule of 5 [10] says that for a molecule to present with good oral bioavailability it must obey certain parameters considered as rule of five and this molecule can not violate more than one of these ... See full document
7
Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics
... respective study indicates substantial changes in response rates between the two ...between study and clinical charac- teristics in disease severity and pretreatment activity between patients treated with ... See full document
6
<p>Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?</p>
... this study, the other drug used was MMF;, and although this is not the drug of choice to treat arthritis, they compared its effectiveness with that of the BTK ...the study, they observed that treatment with ... See full document
6
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor
... tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations is limited by the emergence of acquired resistance, mostly ascribed to the secondary EGFR-T790M ... See full document
16
Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
... Lenalidomide (Celgene Corp., Summit, NJ, USA), a second-generation IMiD, is more potent than thalidomide and has a different toxicity profile. In a study of 68 patients with MF treated with lenalidomide, 33 % ... See full document
7
FINDING NEW INHIBITORS FOR EML4-ALK FUSION PROTEIN: A COMPUTATIONAL APPROACH
... Current study shows binding affinity of active inhibitors for the EML4-ALK, downloaded from ligand database to characterize interaction features using GLIDE (Schrodinger) and to interpret inhibition ... See full document
6
In Silico Designing of Novel Thiazolidine-2-one Derivatives as Dual PDE4/7 Inhibitors for Inflammatory Disorders
... Dual inhibitors of PDE4/7 are a novel class of drug candidates which can regulate pro-inflammatory as well as function of immune T-cell and are particularly beneficial for the treatment of various inflammatory ... See full document
14
Erythrocytic Casein Kinase II Regulates Cytoadherence of Plasmodium falciparum-infected Red Blood Cells
... Specific inhibitors and enhancers have been used to identify erythrocytic casein kinase II (CKII) as the enzyme responsible for VARC modification ...this study fur- thers our understanding of VARC ... See full document
10
Computational Modelling, Synthesis and Biological Evaluation of Guanidinium like Derivatives as Protein Kinase Inhibitors for the Treatment of Cancer
... I am also grateful to all the wonderful people in Rozas’ group I had the chance to work with. Previous members, Paddy in particular, helped me answering chemistry questions and solving problems and, more importantly, ... See full document
362
New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors
... domain of the EGFR [31,32]. It is unknown whether breast tumors contain similar mutations, or whether such mutations predict response to EGFR inhibitors. Other groups have focused on predictors of response to dual ... See full document
7
Computational Multivariate Regression and Validation Analysis on a Set of AKT kinase Inhibitors
... A computational multivariate regression was carried out on a set of 61 pyridine based analogs to study the influence of physico-chemical properties on AKT ...to study the efficacy of AKT inhibition ... See full document
9
Kinase inhibitors: a new class of antirheumatic drugs
... fostamatinib at a dose of 100 mg twice a day or 150 mg twice a day achieved ACR20 responses of 65% and 72%, respec- tively, as opposed to 38% in the placebo group. ACR50 and ACR70 responses were also significantly better ... See full document
6
Histone H3 Phosphorylation in GBM: a New Rational to Guide the Use of Kinase Inhibitors in anti-GBM Therapy
... Histone H3 phosphorylation mainly affect the T3, T6, S10, T11, S28, S31, Y41 and T45 residues [3-5]. H3T3 phosphorylation occurs specifically during mi- tosis and is important for normal alignment of chro- mosomes on the ... See full document
11
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
... a kinase inhibitor library of 274 compounds in 3 different melanoma cell lines that carry a mutated BRAF gene and are wild-type for NRAS: A375 cells with homozy- gous BRAF V600E and IGR37 and 501Mel cells ... See full document
17
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells
... Treatment of LNCaP-AI cells with ABC294640 or SKi induced a concentration- and time-dependent increase in p53 and p21 expression (Figure 1D, 1E), which are markers of growth arrest and senescence, in androgen- ... See full document
13
Medication related issues associated with adherence to long term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study
... UMMC is a tertiary teaching hospital partly financed by the Ministry of Education Malaysia. It is located in Kuala Lumpur, the main business and administrative region in Malaysia. AH is a public hospital located in a ... See full document
8
Combining molecular targeted agents with radiation therapy for malignant gliomas
... randomized study Cilengitide in Combination with Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma phase III Randomized clinical trial (CENTRIC study) of more than 500 patients has assessed ... See full document
17
<p>Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells</p>
... The kinase - AMPK - has been described as an essential regulator of mTOR and cellular metabolism and shown to play an important role in CML pathogenesis 62 and resistance to ... See full document
8
Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib
... Of note, in a recent report, Shaw et al showed a remarkable resensitization of a patient being retreated with crizotinib. The patient exhibited ALK rearrangement and was treated initially with crizotinib. The patient ... See full document
7
<p>Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis</p>
... Our study has shown that different TKI drugs are associated with a highly increased risk of treatment-related toxicity in advanced or RR-DTC. Early interventions and management of TRAEs based on which TKI drugs ... See full document
8
Related subjects